Zn(2+)/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Decreases malondialdehyde (circulating)
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Finding“Four studies showed significantly lower MDA with zinc supplementation (SMD = −0.76; 95% CI −1.34 to −0.18; p = 0.010), with substantial heterogeneity (I 2 = 77%).”
Quoted verbatim from Effects of Zinc Supplementation on Glycemic Control, Insulin Resistance, Inflammation and Oxidative Stress in Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.. - Study
- meta-analysis
- Population
- Adults and children with type 1 or type 2 diabetes, gestational diabetes or prediabetes in 18 pooled RCTs of zinc supplementation against placebo or standard care
Effect -0.76 standardised mean difference, 95% CI -1.34 to -0.18
Effects of Zinc Supplementation on Glycemic Control, Insulin Resistance, Inflammation and Oxidative Stress in Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.2026PMID:42594341Permalink
Keep reading
- Everything the graph holds on Zn(2+)
- Every compound studied against Malondialdehyde (circulating)
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M4PANQ82V61FM8AN3Y1HSK9K